Wirth M., Stojanovic N., Christian J., Paul M.C., Stauber R.H., Schmid R.M., Häcker G., Krämer O.H., Saur D., Schneider G.
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib.
Nucleic Acids Res. 2014;42(16):10433-47.

Bantz C., Koshkina O., Lang T., Galla H.-J., Kirkpatrick C.J., Stauber R.H., Maskos M.
The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions.
Beilstein J. Nanotechnol. 2014, 5:1774-86.

Docter D., Bantz C., Westmeier D., Galla H.J., Wang Q., Kirkpatrick J.C., Nielsen P., Maskos M., Stauber R.H.
The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles.
Beilstein J. Nanotechnol. 2014, 5:1380-92.

Docter D., Distler U., Storck W., Kuharev J,. Wünsch D,. Hahlbrock A., Knauer S.K., Tenzer S., Stauber R.H.
Quantitative profiling of the protein coronas that form around nanoparticles.
Nature Protocols 2014, 9(9):2030-44.

Treuel L., Eslahian K.A., Docter D., Lang T., Zellner R., Nienhaus K., Nienhaus G.U., Stauber R.H., Maskos M.
Physicochemical characterization of nanoparticles and their behavior in the biological environment.
Phys. Chem. Chem. Phys. 2014, 16(29):15053-67.

Ginter T., Fahrer J., Kröhnert U., Fetz V., Garrone A., Stauber R.H,. Reichardt W., Müller-Newen G., Kosan C., Heinzel T., Krämer O.H.
Arginine residues within the DNA binding domain of STAT3 promote intracellular shuttling and phosphorylation of STAT3.
Cell Signal. 2014, 26(8):1698-706.


Eslahian K.A., Lang T., Bantz C., Keller R., Sperling R., Docter D,. Stauber R., Maskos M.
Characterization of Nanoparticles under Physiological Conditions.
In: Bioanalytic reviews; Online first DOI: 10.1007/11663_2014_10. Springer Link.